I don’t believe CEPAC has addressed as sensitive an issue as supplemental screening for dense breast tissue. We heard very moving public testimony from survivors and advocates at the December meeting. About half of women have dense breast tissue and face the questions of determining their risks, whether to have supplemental screening, and if so, what screening to get. An important product of these meetings is the final action guide for patients, clinicians, payers and policymakers – now available for this issue. The action guide ensures that the science doesn’t just sit on a shelf but is translated into real tools to make better decisions. The consumer guide with 5 Questions for Women with Dense Breast Tissue to Ask their Doctor is available in English and Spanish.